Therapy Information

Archive for the ‘Pharmaceuticals’ Category

Pharmaceutical Training for Healthy Businesses

Pharmaceutical training is part of an essential mix of steps that pharmaceutical businesses can take in order to maintain a healthy company. It is essential that all aspects of that business comply with regulations that are set out and implemented to ensure the safety and quality of the products that are produced. The pharmaceutical industry is one of the most heavily regulated industries in the world – understandable given the nature of the products that are being produced – and so therefore many pharmaceutical companies will be the first to admit that the keeping on top of current legal requirements and government regulations can be hard work.

Pharmaceutical training consultants can help pharmaceutical organisations with this problem. Often run by pharmaceutical professionals with vast experience of working in the industry, pharmaceutical training consultants will usually be highly qualified, holding degrees in relevant scientific or pharmaceutical subjects as well as often being educated to second or even third degree level.

It’s important for all businesses to make sure that the pharmaceutical training consultants that they employ have the recognised industry standards of education and experience. Without these basic levels of knowledge and expertise, a person who then calls him or herself a pharmaceutical training consultant is really pushing the boundaries of what could be called the truth.

Abstract

This paper is concerned with the impacts of strict patents in the pharmaceutical industry, focusing on the Trade Related Aspects of Intellectual Property Rights (TRIPs) Agreement. It discusses the historical and current policy context, to better understand how strict patents affect the availability of essential drugs in developing countries.

The research shows that the pharmaceutical industry prioritises profit above health. Strict patents reduce the availability and affordability of new essential drugs in developing countries, and thereby have a negative impact on the health of the world’s poor. Larger pharmaceutical companies benefit more than smaller companies because they have a monopoly in the industry. They invest more in research and development and, linked to economies of scale, are better positioned to exploit markets for new drugs.

Pharmaceutical Outsourcing: Opportunity for India!

The global pharmaceutical markets were estimated at US2bn in the year 2008 growing at 6.4 percent over 2006. This has grown at a compounded annual growth rate (CAGR) of 10.7 percent for the period 2002-07. The market size of USA is estimated at US5-305bn with an estimated growth rate of 4-5 percent. It is followed by Top 5 European countries (EU-5) with an estimated market size of US5-145bn growing at 4-5%, emerging markets VIZ., Brazil, China, India, Mexico, Russia, South Korea and Turkey with an estimated market size of US-90bn. (growing at 12-13%) and Japan with an estimated market size of US-68bn (growing at 1-2%). The pharmaceutical market size of the rest of the world (ROW) is estimated at US5-135bn which is estimated to grow at 7-8 percent in the coming years.

The Indian Pharmaceuticals sector has come a long way, being almost non-existing during 1970, to a prominent provider of health care products, meeting almost 95% of country’s pharmaceutical needs. The pharmaceutical sector is emerging as one of the major contributors to Indian exports with export earnings rising from a negligible amount in early 1990s to Rs.29,139.57 crores by 2007-08. The exports of Drugs,  pharmaceuticals & fine chemicals of India were growing at a compounded annual growth rate (CAGR) of 17.8% during the five year period 2003-04 to 2007-08.

Only two decades ago, China was a poor agricultural country; now it becomes the third-largest economy in the world, with a GDP of more than , 108 billion in 2006. Experts forecast that by 2020, China will be the world’s largest economy.

1, China’s pharmaceutical market

The has shown impressive growth in recent years, in tandem with the country’s rapid economic expansion. In the past twenty years, China’s pharmaceutical market has an averaging between 18 – 20% growth, significantly higher than US and European growth during that period (7 – 9%). The total pharmaceutical market is expected to grow to .7 billion by the year 2005, to become the world’s largest pharmaceutical market by 2020.

The prescription pharmaceutical market in Australia was valued at .1 billion in 2009. Key growth drivers include the growing use of chronic high-value innovative treatments driven by a rising elderly population and high public spending as a proportion of total healthcare expenditure.

Scope

* Overview of Australia’s socioeconomics and demographics, healthcare system, regulation, pricing and reimbursement and intellectual property position.

* Assesses the size of Australia’s pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies.

* Examines Australia’s generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion.

Pharmaceutical Sales: Arizona Job Opportunities

Pharmaceutical companies shoulder the responsibility of developing and commercializing the already discovered drugs in practice and those that are still under research for those medical conditions to which drugs haven’t been yet invented. The job of pharmaceutical sales demands the employees to make a certain amount of sales which would be pre-determined and is called the sales target, within a territory demarcated for the specific agent.

Jobs concerning pharmaceutical sales in Arizona are offered by various companies based in Arizona like- Senes Tech based in Flagstaff, Becton Dickinson located in Nogales, Bayer, Genzyme etc in Phoenix, Medicis Pharmaceuticals, Zila etc in Scottsdale, Ampli Med, Sanofi-Aventis etc located in Tuscon etc.

A candidate, who is successful in fulfilling the criteria for Arizona pharmaceutical sales employment, is eligible to a salary of -74K in the beginning and it could gradually increase to -95K approx per year or more. This also depends on the experience of the candidate. Greater the experience better the pay. There are also opportunities for commission in addition to the fixed salary which goes up to 21K per annum or more based on the amount of hard work put in and the results of the hard work.

HOW TO FIND THE PERFECT PHARMACEUTICAL CONSULTANT

When you are in the pharmaceutical business you know well that sometimes research can be very promising, but much time and effort must be put into it before it turns out a final product. A great deal of clinical trials, certifications, and approvals must be overcome before the product can reach the market. And still after that, a lot of regulations and an extremely competitive market make it almost impossible for companies to survive without a good amount of help to show them the right way to do things.

This type of help can only come from the hands of the specialists in the area, the pharmaceutical consultants. They are the ones to provide you with the right advice to improve your productivity, solve clinical operations issues, creating a new brand and much more.

However, finding the right pharmaceutical consultant for your business may be a difficult task, since there are plenty of consulting firms already in the market, and at first, they may all look the same. Here is a list of the aspects to take into account prior to any decision related to changes that will affect your pharmaceutical business:

1. DEFINE YOUR NEEDS

Prior to any further analysis from a consulting firm, it is important to set your goals as a company, and see specifically what issues you want to solve, or what areas you want to emphasize.